Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Randomized phase III study of canfosfamide in combination with pegylated liposomal doxorubicin compared with pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer
Cutler says it's interesting that only 4% of account holders contribute the maximum allowed in terms of an annual contribution, which is about $8,500 a year compared to about $24,000 for a 401(k) plan
A large-scale trial addressing this question is currently underway
Only 3.2% of participants stopped treatment because of nausea
Regulatory and commercial factors rather than safety concerns explain this limitation
Amino Acids 49 , 20912098 (2017)
US$ 25.44
US$ 26.59
US$ 24.95
US$ 22.87
US$ 28.98
